Collagenase from Clostridium Histolyticum

<strong>Collagenase from Clostridium histolyticum</strong>_x000D_ <strong>Catalog number:</strong> B2010529_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> 68-125 kDa_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> molecular tool in various cellular biology applications_x000D_ <strong>Storage:</strong> −20°C_x000D_ <strong>Keywords:</strong> Clostridiopeptidase A_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Amighi A, Eleswarapu SV, Mendhiratta N, Nork JJ, Mills JN. Discontinuation_x000D_ from Collagenase Clostridium histolyticum Therapy for Peyronie's Disease: Review_x000D_ and Single-Center Cohort Analysis. Sex Med Rev. 2019 Oct;7(4):690-698._x000D_ _x000D_ 2: Mills SA, Gelbard MK. Sixty years in the making: collagenase Clostridium_x000D_ histolyticum, from benchtop to FDA approval and beyond. World J Urol. 2020_x000D_ Feb;38(2):269-277._x000D_ _x000D_ 3: Sadick NS, Goldman MP, Liu G, Shusterman NH, McLane MP, Hurley D, Young VL._x000D_ Collagenase Clostridium Histolyticum for the Treatment of Edematous_x000D_ Fibrosclerotic Panniculopathy (Cellulite): A Randomized Trial. Dermatol Surg._x000D_ 2019 Aug;45(8):1047-1056._x000D_ _x000D_ 4: Hoy SM. Collagenase Clostridium Histolyticum: A Review in Peyronie's Disease._x000D_ Clin Drug Investig. 2020 Jan;40(1):83-92._x000D_ _x000D_ 5: Cocci A, Russo GI, Salamanca JIM, Ralph D, Palmieri A, Mondaini N. The End of_x000D_ an Era: Withdrawal of Xiapex (Clostridium histolyticum Collagenase) from the_x000D_ European Market. Eur Urol. 2020 May;77(5):660-661._x000D_ _x000D_ 6: Smeraglia F, Del Buono A, Maffulli N. Collagenase clostridium histolyticum in_x000D_ Dupuytren's contracture: a systematic review. Br Med Bull. 2016_x000D_ Jun;118(1):149-58._x000D_ _x000D_ 7: Jensen CFS, Jacobsen FM, Quallich S, Fode M, Sønksen J, Malaeb BS, Ohl DA;_x000D_ CopMich Collaborative. Patient-reported outcomes from a single-centre_x000D_ prospective post-marketing study on Collage_nase Clostridium Histolyticum_x000D_ injections for Peyronie's disease. Andrologia. 2020 Nov;52(10):e13733._x000D_ _x000D_ 8: Cook J, Waughtel J, Andreoni AR, Sakharpe A, Friedman DW. Collage_nase_x000D_ Clostridium Histolyticum for Dupuytren's Contracture: Comparing Single and_x000D_ Concurrent Injections. Plast Reconstr Surg. 2019 Apr;143(4):782e-787e._x000D_ _x000D_ 9: Capece M, Arcaniolo D, Manfredi C, Palmieri A, De Sio M, Verze P, Fusco F,_x000D_ Longo N, Mirone V. Second cycle of intralesional Collagenase Clostridium_x000D_ histolyticum for Peyronie's disease using the modified shortened protocol:_x000D_ Results from a retrospective analysis. Andrologia. 2020 Apr;52(3):e13527._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/32459883/">10: Harvey N, Pearce I. At what cost is collagenase clostridium histolyticum_x000D_ viable for treating Peyronie's disease in a public healthcare system? Andrology._x000D_ 2020 Sep;8(5):1304-1311. </a>_x000D_ _x000D_ <strong>Products Related to Collagenase from Clostridium histolyticum</strong><a href="https://moleculardepot.com/product-category/Proteins/">: Proteins</a>